Project description DEENESFRITPL Promoting excellence in immunology research in Portugal The mission of the EU-funded ImmunoHUB project is to create a platform of excellence in research and innovation at Instituto de Biologia Molecular e Celular (IBMC-i3S) in Portugal. Cancer, infectious diseases, autoimmunity, and neurodegenerative disorders are studied at IBMC-i3S with the focus on the immune response deregulation. The ImmunoHUB will advance immunology at IBMC-i3S towards the forefront of basic and translational biomedical research, providing knowledge, promoting the best academic practices to train the next generation of immunologists and raising public awareness in immunology. The project is aligned with the existing scientific policy in Portugal and with the ERA priorities identified under the H2020 program. Show the project objective Hide the project objective Objective The mission of an ERA Chair in Immunology (ImmunoHUB) is to create a Platform of excellence in research and innovation at IBMC-i3S (Portugal). Cancer, infectious diseases, autoimmunity and neurodegenerative disorders are major problems affecting our society. These pathologies are studied at IBMC-i3S and result in in part from deregulated immune responses, which makes Immunology a core pillar in our institute. Moreover, the successful usage of immune checkpoint blockade therapies has revolutionized the treatment of cancer and highlights the importance of understanding how to harness the Immune system for future development of vaccines or therapeutics against these diseases. Despite the contributions of our research groups for the understanding of how immune responses are orchestrated in health and disease, the international visibility of IBMC-i3S as a research center of Excellence in Immunology remains modest.The ImmunoHUB action will (1) project Immunology at IBMC-i3S towards the forefront of basic and translational biomedical research, (2) provide knowledge of fundamental and economical value, (3) promote the finest academic practices to train the next generation of Immunologists and (4) widen public awareness for the importance of Immunology. Taking advantage of our high-quality scientific, technological, administrative and governance structures, we have set a comprehensive work plan to facilitate the integration and sustainability of the ERA Chair team and the implementation of the ImmunoHUB project. Our proposal is aligned with the existing scientific policy in Portugal and with the Societal Challenges and the ERA priorities identified by the European Commission under the H2020 program. Together, these synergistic actions will play a pivotal role to equip Portugal with the cornerstone infrastructures and human resources of the highest level to reach scientific excellence in Biomedical Research across Europe. Fields of science medical and health scienceshealth sciencesinfectious diseasesmedical and health sciencesbasic medicineimmunologymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccinesmedical and health sciencesclinical medicineoncologymedical and health sciencesbasic medicinepathology Programme(s) H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme Topic(s) WIDESPREAD-06-2020 - ERA Chairs Call for proposal H2020-WIDESPREAD-2018-2020 See other projects for this call Sub call H2020-WIDESPREAD-2018-2020-6 Funding Scheme CSA - Coordination and support action Coordinator INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC Net EU contribution € 2 475 826,25 Address Rua alfredo allen 208 4200 135 Porto Portugal See on map Region Continente Norte Área Metropolitana do Porto Activity type Research Organisations Links Contact the organisation Opens in new window Website Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00
